ERBB2 and breast cancer: One of the major differences is that the circular and complete membranous staining required to confirm HER2-positivity in breast cancer is rare in this form in gastric cancer and is not a defining characteristic for HER2-positivity in this setting (Barros-Silva et al. 2009).